00310-0512 Calquence - CanMED: NDC

Product NDC:

00310-0512

Brand Name:

Calquence

Generic Name:

Acalabrutinib

Dosage Form Name:

CAPSULE, GELATIN COATED

Administration Route:

Oral

Substances:

Name: Acalabrutinib

Strength: 100.0

Unit: mg/1

Packages:

Code: 00310-0512-28

Description: 28 CAPSULE, GELATIN COATED in 1 BOTTLE (0310-0512-28)

Effective Date: April 1, 2018

Discontinued: July 31, 2021

Code: 00310-0512-60

Description: 60 CAPSULE, GELATIN COATED in 1 BOTTLE (0310-0512-60)

Effective Date: Oct. 31, 2017

Discontinued:

Code: 00310-0512-95

Description: 60 CAPSULE, GELATIN COATED in 1 BOTTLE (0310-0512-95)

Effective Date: April 1, 2020

Discontinued: July 31, 2025

SEER*Rx Category:

Chemotherapy

Major Class:

Tyrosine Kinase Inhibitor

Minor Class:

BTK

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox